2nd Quarter - Report

OGR for ECOLAB INC. ON BEHALF OF NALCO COMPANY

Firm
OGR
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade issues and international items including the US-UK bilateral and the MTB legislative process.

LobbyistCovered position, as disclosed
DEAN AGUILLEN —
MICHAEL DEE BUCHANAN —
STANTON BULLOCK —
CHRIS GIBLIN —
CONRAD LASS —
MOSES MERCADO —
TUCKER SHUMACK —
GORDON TAYLOR —

Contacted: Treasury, Dept of; Food & Drug Administration (FDA); White House Office; SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Taxation legislation affecting the industry, including: Implementation of Tax Cuts and Jobs Act (P.L.115-97); H.R.748, CARES Act (P.L.116-136); H.R.6800, The Heroes Act; H.R.7079, Clean Start: Back to Work Tax Credit Act.

LobbyistCovered position, as disclosed
DEAN AGUILLEN —
MICHAEL DEE BUCHANAN —
STANTON BULLOCK —
CHRIS GIBLIN —
CONRAD LASS —
MOSES MERCADO —
TUCKER SHUMACK —
GORDON TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; Food & Drug Administration (FDA); SENATE; White House Office

Bills named: H.R. 7079 (116th), H.R. 748 (116th), H.R. 6800 (116th)

Health Issues HCR

Issues related to the decontamination of masks.

LobbyistCovered position, as disclosed
DEAN AGUILLEN —
MICHAEL DEE BUCHANAN —
STANTON BULLOCK —
CHRIS GIBLIN —
CONRAD LASS —
MOSES MERCADO —
TUCKER SHUMACK —
GORDON TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; SENATE; White House Office; Food & Drug Administration (FDA)

Environment/Superfund ENV

Environmental issues related to water reuse, water efficiency, and water resource management; S.3591, America's Water Infrastructure Act of 2020; S.3590, Drinking Water Infrastructure Act of 2020.

LobbyistCovered position, as disclosed
DEAN AGUILLEN —
MICHAEL DEE BUCHANAN —
STANTON BULLOCK —
CHRIS GIBLIN —
CONRAD LASS —
MOSES MERCADO —
TUCKER SHUMACK —
GORDON TAYLOR —

Contacted: Treasury, Dept of; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: S. 3590 (116th), S. 3591 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.